The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic landscape and therapeutic implications in advanced solid cancers: KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors, KCSG AL-22-09).
 
Heejung Chae
No Relationships to Disclose
 
Harim Koo
No Relationships to Disclose
 
Sun Young Kim
Honoraria - Boryung; LG Chem; Merck
Consulting or Advisory Role - Guardant Health; Ono Pharmaceutical
Research Funding - Roche/Genentech (Inst)
Expert Testimony - Guardant Health
 
Sook Ryun Park
Honoraria - BMS Korea; MSD
Consulting or Advisory Role - BeiGene; Pfizer Pharmaceuticals Korea Ltd.
Research Funding - ImmuneOncia (Inst); Incyte (Inst); Ono Pharmaceutical
 
Shinkyo Yoon
Honoraria - MSD Oncology
Consulting or Advisory Role - Boryung Pharmaceuticals; Daiichi Sankyo
 
Min-Hee Ryu
Honoraria - Astellas Pharma; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; DAEHWA Pharmaceutical; Daiichi Sankyo; Lilly; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - AstraZeneca; Bristol-Myers Squibb (Inst); Ono Pharmaceutical (Inst)
 
Soohyeon Lee
Stock and Other Ownership Interests - Celgene/Bristol-Myers Squibb; Pfizer
Consulting or Advisory Role - PharmAbcine
Research Funding - Jeil Pharmaceutical Co
Travel, Accommodations, Expenses - ST Cube
 
Tae-Yong Kim
No Relationships to Disclose
 
Tae Min Kim
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; BeiGene; Daiichi Sankyo/Astra Zeneca; inno.N; Janssen Oncology; Novartis; Regeneron; Samsung Bioepis; Takeda
Speakers' Bureau - AstraZeneca/MedImmune; IMBdx; Janssen Research & Development; Takeda
(OPTIONAL) Uncompensated Relationships - Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene (Inst); Black Diamond Therapeutics (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Boryung (Inst); Dizal Pharma (Inst); Fore Biotherapeutics (Inst); Genmab (Inst); Hanmi (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); RAPT Therapeutics (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
 
Sae-Won Han
Honoraria - IMBdx
Research Funding - Arcus Biosciences (Inst); BeyondBio (Inst); GC Pharma (Inst); Genentech (Inst); Hanmi (Inst); Hengrui Pharmaceutical (Inst); IMBdx (Inst); Janssen (Inst); Jeil Pharmaceutical Co (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Mirati Therapeutics (Inst); MSD (Inst); Roche (Inst); Seagen (Inst); Turnstone Bio (Inst)
 
Se-Hoon Lee
Honoraria - Amgen; AstraZeneca/MedImmune; Lilly; Merck Sharp & Dohme; Roche; Yuhan
Consulting or Advisory Role - Abion; AstraZeneca; BeiGene; BMS/Ono; Daiichi Sankyo; IMBdx; ImmuneOncia; Janssen; Lilly; Merck (German); Merck Sharp & Dohme; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Abion
Research Funding - AstraZeneca (Inst); Lunit (Inst); Merck Sharp & Dohme (Inst)
 
Hyun Ae Jung
Consulting or Advisory Role - AIMEDBIO; Guardant Health; Yuhan
Research Funding - Yuhan
 
Hye Ryun Kim
Speakers' Bureau - ABL Bio; Ono Pharmaceutical; Roche/Genentech
 
Minkyu Jung
Employment - Ensol Biosciences (I)
Stock and Other Ownership Interests - Ensol Biosciences; Ensol Biosciences (I)
Honoraria - Celltrion; Lilly
 
Gyeong-Won Lee
No Relationships to Disclose
 
Mi Sun Ahn
No Relationships to Disclose
 
Hongseok Yun
No Relationships to Disclose
 
Yoon-La Choi
Employment - abion (I)
Stock and Other Ownership Interests - abion (I)
Consulting or Advisory Role - LG Chem
Speakers' Bureau - J&J
 
Sejoon Lee
No Relationships to Disclose
 
Jee Hyun Kim
Honoraria - AstraZeneca; Lilly; Roche; Roche; Roche
Consulting or Advisory Role - Bixink; Eisai; Everest Medicine; MSD; Roche; Yuhan
Research Funding - Eisai (Inst); Ono Pharmaceutical (Inst); Roche (Inst)